Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chien-Fu Hung

Showing results (61-70 of 265) with videos related to

Pageof 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2021
Cervical Cancer Immunotherapy: Facts and HopesLouise Ferrall, Ken Y Lin, Richard B S Roden, et al.
Infection and Immunity|February 21, 2008
Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvantYong Sung Park, Jin Hyup Lee, Chien-Fu Hung, et al.
Plos Biology|December 21, 2021
Evolutionary pathways to SARS-CoV-2 resistance are opened and closed by epistasis acting on ACE2Gianni M Castiglione, Lingli Zhou, Zhenhua Xu, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 28, 2006
Vaccines against human papillomavirusYen-Yu Lin, Hannah Alphs, Chien-Fu Hung, et al.
Human Gene Therapy|January 11, 2018
Therapeutic DNA Vaccines for Human Papillomavirus and Associated DiseasesMax A Cheng, Emily Farmer, Claire Huang, et al.
Vaccine|October 13, 2007
Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potencyBruce Huang, Chih-Ping Mao, Shiwen Peng, et al.
Human Gene Therapy|December 28, 2012
Innovative DNA vaccine to break immune tolerance against tumor self-antigenTae Heung Kang, Chih-Ping Mao, Victor La, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesionsShiwen Peng, Cornelia Trimble, Lee Wu, et al.
Vaccine|September 24, 2014
Cancer immunotherapy using a potent immunodominant CTL epitopeLiwen Song, Ming-Chieh Yang, Jayne Knoff, et al.
Expert Review of Vaccines|February 23, 2016
Current state in the development of candidate therapeutic HPV vaccinesAndrew Yang, Jessica Jeang, Kevin Cheng, et al.
Pageof 27

Showing results (61-70 of 265) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2021
Cervical Cancer Immunotherapy: Facts and HopesLouise Ferrall, Ken Y Lin, Richard B S Roden, et al.
Infection and Immunity|February 21, 2008
Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvantYong Sung Park, Jin Hyup Lee, Chien-Fu Hung, et al.
Plos Biology|December 21, 2021
Evolutionary pathways to SARS-CoV-2 resistance are opened and closed by epistasis acting on ACE2Gianni M Castiglione, Lingli Zhou, Zhenhua Xu, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 28, 2006
Vaccines against human papillomavirusYen-Yu Lin, Hannah Alphs, Chien-Fu Hung, et al.
Human Gene Therapy|January 11, 2018
Therapeutic DNA Vaccines for Human Papillomavirus and Associated DiseasesMax A Cheng, Emily Farmer, Claire Huang, et al.
Vaccine|October 13, 2007
Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potencyBruce Huang, Chih-Ping Mao, Shiwen Peng, et al.
Human Gene Therapy|December 28, 2012
Innovative DNA vaccine to break immune tolerance against tumor self-antigenTae Heung Kang, Chih-Ping Mao, Victor La, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesionsShiwen Peng, Cornelia Trimble, Lee Wu, et al.
Vaccine|September 24, 2014
Cancer immunotherapy using a potent immunodominant CTL epitopeLiwen Song, Ming-Chieh Yang, Jayne Knoff, et al.
Expert Review of Vaccines|February 23, 2016
Current state in the development of candidate therapeutic HPV vaccinesAndrew Yang, Jessica Jeang, Kevin Cheng, et al.
Pageof 27